Cost of Revenue of IDEXX LABORATORIES INC /DE from 31 Mar 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
IDEXX LABORATORIES INC /DE quarterly and annual Cost of Revenue in USD history and change rate from 31 Mar 2010 to 31 Mar 2025.
  • IDEXX LABORATORIES INC /DE Cost of Revenue for the quarter ending 31 Mar 2025 was $375,048,000, a 1.1% increase year-over-year.
  • IDEXX LABORATORIES INC /DE annual Cost of Revenue for 2023 was $1,470,983,000, a 7.9% increase from 2022.
  • IDEXX LABORATORIES INC /DE annual Cost of Revenue for 2022 was $1,362,986,000, a 2.8% increase from 2021.
  • IDEXX LABORATORIES INC /DE annual Cost of Revenue for 2021 was $1,325,928,000, a 17% increase from 2020.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

IDEXX LABORATORIES INC /DE Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $375,048,000 +$4,023,000 +1.1% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 $1,510,383,000 $379,505,000 +$11,960,000 +3.3% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $1,498,423,000 $384,419,000 +$13,639,000 +3.7% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,484,784,000 $371,025,000 +$13,801,000 +3.9% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $1,470,983,000 $375,434,000 +$31,793,000 +9.3% 01 Oct 2023 31 Dec 2023 10-K 22 Feb 2024 2023 FY
Q3 2023 $1,439,190,000 $367,545,000 +$32,510,000 +9.7% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $1,406,680,000 $370,780,000 +$24,266,000 +7% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $1,382,414,000 $357,224,000 +$19,428,000 +5.8% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q4 2022 $1,362,986,000 $343,641,000 -$1,028,000 -0.3% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $1,364,014,000 $335,035,000 -$2,465,000 -0.73% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $1,366,479,000 $346,514,000 +$9,680,000 +2.9% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $1,356,799,000 $337,796,000 +$30,871,000 +10% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $1,325,928,000 $344,669,000 +$33,233,000 +11% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $1,292,695,000 $337,500,000 +$38,317,000 +13% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $1,254,378,000 $336,834,000 +$78,584,000 +30% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $1,175,794,000 $306,925,000 +$40,179,000 +15% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $1,135,615,000 $311,436,000 +$37,139,000 +14% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q3 2020 $1,098,476,000 $299,183,000 +$38,830,000 +15% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $1,059,646,000 $258,250,000 -$4,000,000 -1.5% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $1,063,646,000 $266,746,000 +$22,287,000 +9.1% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $1,041,359,000 $274,297,000 +$25,272,000 +10% 01 Oct 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
Q3 2019 $1,016,087,000 $260,353,000 +$20,548,000 +8.6% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $995,539,000 $262,250,000 +$13,937,000 +5.6% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $981,602,000 $244,459,000 +$9,902,000 +4.2% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $971,700,000 $249,025,000 +$15,378,000 +6.6% 01 Oct 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
Q3 2018 $956,322,000 $239,805,000 +$21,831,000 +10% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $934,491,000 $248,313,000 +$32,088,000 +15% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $902,403,000 $234,557,000 +$30,727,000 +15% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q4 2017 $871,676,000 $233,647,000 +$31,277,000 +15% 01 Oct 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
Q3 2017 $840,399,000 $217,974,000 +$16,396,000 +8.1% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $824,003,000 $216,225,000 +$10,199,000 +5% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q1 2017 $813,804,000 $203,830,000 +$13,817,000 +7.3% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $799,987,000 $202,370,000 +$20,380,000 +11% 01 Oct 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
Q3 2016 $779,607,000 $201,578,000 +$19,465,000 +11% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 $760,142,000 $206,026,000 +$25,440,000 +14% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2017 Q2
Q1 2016 $734,702,000 $190,013,000 +$23,080,000 +14% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017 2017 Q1
Q4 2015 $711,622,000 $181,990,000 +$12,196,000 +7.2% 01 Oct 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
Q3 2015 $699,426,000 $182,113,000 +$11,926,000 +7% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016 2016 Q3
Q2 2015 $687,500,000 $180,586,000 +$8,982,000 +5.2% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016 2016 Q2
Q1 2015 $678,518,000 $166,933,000 +$8,827,000 +5.6% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q4 2014 $669,691,000 $169,794,000 +$4,385,000 +2.7% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
Q3 2014 $665,306,000 $170,187,000 +$17,673,000 +12% 01 Jul 2014 30 Sep 2014 10-Q 28 Oct 2015 2015 Q3
Q2 2014 $647,633,000 $171,604,000 +$16,719,000 +11% 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2015 Q2
Q1 2014 $630,914,000 $158,106,000 +$9,974,000 +6.7% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015 2015 Q1
Q4 2013 $620,940,000 $165,409,000 +$14,921,000 +9.9% 01 Oct 2013 31 Dec 2013 10-K 17 Feb 2016 2015 FY
Q3 2013 $606,019,000 $152,514,000 +$7,674,000 +5.3% 01 Jul 2013 30 Sep 2013 10-Q 24 Oct 2014 2014 Q3
Q2 2013 $598,345,000 $154,885,000 +$3,925,000 +2.6% 01 Apr 2013 30 Jun 2013 10-Q 25 Jul 2014 2014 Q2
Q1 2013 $594,420,000 $148,132,000 +$230,000 +0.16% 01 Jan 2013 31 Mar 2013 10-Q 25 Apr 2014 2014 Q1
Q4 2012 $594,190,000 $150,488,000 +$2,168,000 +1.5% 01 Oct 2012 31 Dec 2012 10-K 17 Feb 2015 2014 FY
Q3 2012 $592,022,000 $144,840,000 +$2,553,000 +1.8% 01 Jul 2012 30 Sep 2012 10-Q 22 Oct 2013 2013 Q3
Q2 2012 $589,469,000 $150,960,000 +$7,131,000 +5% 01 Apr 2012 30 Jun 2012 10-Q 23 Jul 2013 2013 Q2
Q1 2012 $582,338,000 $147,902,000 +$10,155,000 +7.4% 01 Jan 2012 31 Mar 2012 10-Q 23 Apr 2013 2013 Q1
Q4 2011 $572,183,000 $148,320,000 +$9,334,000 +6.7% 01 Oct 2011 31 Dec 2011 10-K 18 Feb 2014 2013 FY
Q3 2011 $562,849,000 $142,287,000 +$14,866,000 +12% 01 Jul 2011 30 Sep 2011 10-Q 19 Oct 2012 2012 Q3
Q2 2011 $547,983,000 $143,829,000 +$11,631,000 +8.8% 01 Apr 2011 30 Jun 2011 10-Q 20 Jul 2012 2012 Q2
Q1 2011 $536,352,000 $137,747,000 +$11,583,000 +9.2% 01 Jan 2011 31 Mar 2011 10-Q 20 Apr 2012 2012 Q1
Q4 2010 $524,769,000 $138,986,000 01 Oct 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY
Q3 2010 $127,421,000 01 Jul 2010 30 Sep 2010 10-Q 21 Oct 2011 2011 Q3
Q2 2010 $132,198,000 01 Apr 2010 30 Jun 2010 10-Q 22 Jul 2011 2011 Q2
Q1 2010 $126,164,000 01 Jan 2010 31 Mar 2010 10-Q 21 Apr 2011 2011 Q1

IDEXX LABORATORIES INC /DE Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,470,983,000 +$107,997,000 +7.9% 01 Jan 2023 31 Dec 2023 10-K 22 Feb 2024 2023 FY
2022 $1,362,986,000 +$37,058,000 +2.8% 01 Jan 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
2021 $1,325,928,000 +$190,313,000 +17% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $1,135,615,000 +$94,256,000 +9.1% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $1,041,359,000 +$69,659,000 +7.2% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $971,700,000 +$100,024,000 +11% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $871,676,000 +$71,689,000 +9% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $799,987,000 +$88,365,000 +12% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $711,622,000 +$41,931,000 +6.3% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $669,691,000 +$48,751,000 +7.9% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $620,940,000 +$26,750,000 +4.5% 01 Jan 2013 31 Dec 2013 10-K 17 Feb 2016 2015 FY
2012 $594,190,000 +$22,007,000 +3.8% 01 Jan 2012 31 Dec 2012 10-K 17 Feb 2015 2014 FY
2011 $572,183,000 +$47,414,000 +9% 01 Jan 2011 31 Dec 2011 10-K 18 Feb 2014 2013 FY
2010 $524,769,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.